Access. Intelligence. Excellence
New Study Examines How HEOR Function in Pharma is Utilizing Big Data
CHAPEL HILL, N.C., Feb. 13, 2015 /PRNewswire/ -- The Health Economics and Outcomes Research (HEOR) function within the pharmaceutical industry is seen as a group that can find great value in Big Data.
Medical records, clinical trial data and claims information are some of the information sources that pharma can use to produce Big Data insights related to health outcomes and therapies, both under development and in the market.
The last decade has seen an explosion in the availability of data that can deliver valuable insights for the pharmaceutical sector, and in particular the HEOR function. Likewise, the last decade has seen health outcomes become more than a buzzword. Pharma is actively placing an emphasis on how their products and services impact the health status - the health outcomes – of their customers. In short, pharma recognizes the huge potential that Big Data holds for providing critical insights into health outcomes and consequently many organizations are taking steps to develop Big Data capabilities.
To inform these efforts and to probe current trends and best practices in utilizing Big Data, research and consulting leader Best Practices, LLC has published a new benchmarking study, "Big Data in Pharma: Current & Future Trends for Big Data Utilization Across the Health Outcomes Research Function."
The study presents responses from HEOR leaders on key questions around Big Data utilization, including:
- The types of Big Data projects and data being used
- The types of data being used for specific Big Data projects
- The data types and sources that are most valuable
- How companies are organizing their Big Data efforts
- Who are the most useful partners for Big Data projects
Best Practices, LLC engaged 15 leaders from 13 pharmaceutical companies through a benchmarking survey to discuss how their companies approach Big Data utilization within HEOR. Research analysts also conducted deep-dive executive interviews with selected benchmark participants.
To learn more about this report, download a complimentary report excerpt at http://www3.best-in-class.com/rr1332.htm.
For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking and advisory services firm serving pharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and most of the top 50 pharmaceutical companies. The firm conducts primary research and uses its comprehensive benchmarking tools and executives interviews to form the basis for our Benchmarking Reports and advisory services utilized by top executives. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.
ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE